Title:
SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK PROTEIN KINASE INHIBITOR AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/135421
Kind Code:
A1
Abstract:
Disclosed in the present invention are a salt form of an isoquinolinone type compound as a ROCK protein kinase inhibitor and a preparation method therefor; and use of the salt form in the preparation of a medicament for treating diseases such as glaucoma or ocular hypertension is further comprised.
Inventors:
GE JIAN (CN)
WANG YANDONG (CN)
LIU YIZHI (CN)
WU LINGYUN (CN)
YOU XU (CN)
XIAO ZHEMING (CN)
CHEN SHUHUI (CN)
WANG YANDONG (CN)
LIU YIZHI (CN)
WU LINGYUN (CN)
YOU XU (CN)
XIAO ZHEMING (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2021/140206
Publication Date:
June 30, 2022
Filing Date:
December 21, 2021
Export Citation:
Assignee:
GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07D401/12; A61K31/551; A61P7/02; A61P9/08; A61P9/10; A61P9/12; A61P27/06
Domestic Patent References:
| WO2020253882A1 | 2020-12-24 | |||
| WO2007026664A1 | 2007-03-08 | |||
| WO2006057397A1 | 2006-06-01 | |||
| WO2007026664A1 | 2007-03-08 |
Foreign References:
| CN101622243A | 2010-01-06 | |||
| CN105085478A | 2015-11-25 | |||
| CN101068806A | 2007-11-07 | |||
| CN202011521011A | 2020-12-21 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: